Skip to main content
Clinical Trials/JPRN-UMIN000010629
JPRN-UMIN000010629
Recruiting
未知

Percutaneous transvenous aortic valvuloplasty with a new method - Percutaneous transvenous aortic valvuloplasty with a new method

Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University0 sites2 target enrollmentMay 1, 2013

Overview

Phase
未知
Intervention
Not specified
Conditions
Aortic valve stenosis
Sponsor
Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University
Enrollment
2
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

/A

Registry
who.int
Start Date
May 1, 2013
End Date
March 31, 2019
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\. Acute myocardial infarction within 1 month. 2\. Unicuspid aortic valve. 3\. Severe aortic valve regurgitation. 4\. Prior valve surgery. 5\. Need of the emergency surgery by some kind of reasons why an aortic stenosis does not have relations. 6\.Obstructive or nonobstructive cardiomyopathy. 7\. Severe LV dysfunction (LVEF\<20%). 8\. Active gastrointestinal ulcer or history of upper gastrointestinal bleeding within 3 months. 9\. Allergy to heparin. 10\. CVA or TIA within 6 month. 11\. Life expectancy less than 12 months due to non\-cardiac disease. 12\. Involvement in another clinical trial. 13\. Allergy to latex. 14\. Making the safe insertion of sheath introducer impossible by thrombosis from the common iliac vein through the femoral vein. 15\. Cardiologist and cardiovascular surgeon decision not to register to this study.

Outcomes

Primary Outcomes

Not specified

Similar Trials